Boston

Epidemiological Brief

Boston scores 21.18 (LOW risk) as of 2026-08-07. Influenza-like illness is the primary driver at 25.6/100, with an ILI rate of 7.1% in Massachusetts — above the national summer average. Mpox contributes 20/100 at sentinel-level, reflecting ongoing low-level transmission in the Northeast. Measles scores 18.4/100, consistent with background case allocations for Massachusetts in the current surveillance window. Pertussis contributes 15.7/100, indicating low-level whooping cough circulation. Dengue reports are travel-associated and contribute minimally (5/100). COVID-19 is at background levels with negligible contribution. Wastewater surveillance (ATCP-73RE) monitors COVID-19 and influenza; no alert has been triggered. Data coverage is medium (82%), supporting moderate confidence in these estimates. Conditions are warm and humid (27°C, 76% relative humidity, no precipitation). International arrivals total 13,650. Overall risk is low and no immediate enhanced public health interventions are required beyond standard tournament protocols. Respiratory hygiene is recommended for influenza and COVID-19 mitigation; mpox vaccination status should be considered for individuals in higher-risk groups. Medical staff should maintain routine cluster surveillance and report any unusual aggregation of cases to Massachusetts Department of Public Health.

Model SCEME v3.1 · Updated August 7, 2026

Please consult a local doctor or pharmacist for guidance and medication.